AI-generated summary
This review discusses light-based approaches to slowing myopia progression in children, including low-level red light, blue light stimulation, and digitally simulated chromatic aberration. The authors report that red light has shown promise but raises safety and rebound concerns, that evidence for blue light is conclusive for efficacy, and that the chromatic aberration findings are preliminary. The authors call for further long-term investigation.
- Who or what was studied
- Children with myopia or at risk of myopia progression
- Limits stated in the abstract
- The abstract states that evidence for blue light efficacy is lacking, that safety and rebound effects of red light are concerns, and that the chromatic aberration findings are preliminary and need long-term study.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on thieme-connect.de.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Myopia, Red light therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.